EMA Finds Scientific Advice Leads to Stronger Trial Design
这有助于提前解决潜在问题。 提交事前咨询请求: 针对FDA,您可以通过Pre-Submission(事前咨询)程序向FDA提交请求,而EMA可以通过Scientific Advice(科学建议)程序提供咨询。 3. 制定和提交申请: 制定全面的申请: 根据监管机构的要求,制定全面的申请文件,确保包括所有必要的信息和支持文件。 制定临床试验计划: 如果您的...
在计划阶段与监管机构进行初步沟通,以获取关于试验设计和提交要求的反馈。 提交初步研究计划(Protocol Assistance,FDA)或药物开发咨询(Scientific Advice,EMA)申请,以获取监管机构的意见。 申请准备: 制定完整的研究计划,包括研究设计、试验流程、数据收集和分析计划等。 编写适当的文档,包括研究方案、病例报告表(Case Repo...
4、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档 内容提供方:药品研究 审核时间:2023-10-25 审核编号:8101064042006000 认证类型:实名认证 能力类型:文档贡献者 领域认证: 版权证书: 区块链号:...
2023. Available at: https://www.abbvie.com/our-science/pipeline.html. Accessed April 17, 2024. A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants with Giant Cell Arteritis (SELECT-GCA). ClinicalTrials.gov. Available at:...
EMA publishes parallel scientific adviceThe article reports on the European Medicines Agency's publication of its parallel scientific advice on drug development from health technology assessment organizations and regulators.doi:10.1038/nrd4358NoneNature Reviews Drug Discovery...
As medicines development continues towards a globalized approach, both the pharmaceutical industry and regulatory agencies increasingly seek opportunities to proactively engage early in product development. The parallel scientific advice program shared by the European Medicines Agency (EMA) and the US Food ...
EMA Releases Report on Parallel Scientific Advice with HTA Bodies
The article reports that the European Medicines Agency (EMA) has published a report to offer provide parallel regulatory scientific advice with health-technology assessment (HTA) bodies that allows drug developers to receive simultaneous feedback on the development plans....
Scientific Advice Strategy: Working with EMA and FDA